HR c.247A>G ;(p.N83D)

Variant ID: 8-21986437-T-C

NM_005144.4(HR):c.247A>G;(p.N83D)

This variant was identified in 5 publications

View GRCh38 version.




Publications:


Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases.

Cell Death & Disease
Grassi, Ludovica L; Alfonsi, Romina R; Francescangeli, Federica F; Signore, Michele M; De Angelis, Maria Laura ML; Addario, Antonio A; Costantini, Manuela M; Flex, Elisabetta E; Ciolfi, Andrea A; Pizzi, Simone S; Bruselles, Alessandro A; Pallocca, Matteo M; Simone, Giuseppe G; Haoui, Mustapha M; Falchi, Mario M; Milella, Michele M; Sentinelli, Steno S; Di Matteo, Paola P; Stellacci, Emilia E; Gallucci, Michele M; Muto, Giovanni G; Tartaglia, Marco M; De Maria, Ruggero R; Bonci, Désirée D
Publication Date: 2019-02-27

Variant appearance in text: HR: 247A>G
PubMed Link: 30814510
Variant Present in the following documents:
  • 41419_2019_1453_MOESM27_ESM.xlsx, sheet 2
View BVdb publication page



Characterization of minority HIV-1 drug resistant variants in the United Kingdom following the verification of a deep sequencing-based HIV-1 genotyping and tropism assay.

Aids Research And Therapy
Silver, Nicholas N; Paynter, Mary M; McAllister, Georgina G; Atchley, Maureen M; Sayir, Christine C; Short, John J; Winner, Dane D; Alouani, David J DJ; Sharkey, Freddie H FH; Bergefall, Kicki K; Templeton, Kate K; Carrington, David D; Quiñones-Mateu, Miguel E ME
Publication Date: 2018-11-08

Variant appearance in text: HR: N83D
PubMed Link: 30409215
Variant Present in the following documents:
  • 12981_2018_Article_206.pdf
View BVdb publication page



Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients: A Randomized, Multinational, Multicenter Trial.

Plos One
Cooper, David A DA; Cordery, Damien V DV; Zajdenverg, Roberto R; Ruxrungtham, Kiat K; Arastéh, Keikawus K; Bergmann, Frank F; Neto, José L de Andrade JL; Scherer, Joseph J; Chaves, Ricardo L RL; Robinson, Patrick P; ,
Publication Date: 2016

Variant appearance in text: HR: N83D
PubMed Link: 26730818
Variant Present in the following documents:
  • Main text
  • pone.0144917.pdf
View BVdb publication page



Comparable long-term efficacy of Lopinavir/Ritonavir and similar drug-resistance profiles in different HIV-1 subtypes.

Plos One
Grossman, Zehava Z; Schapiro, Jonathan M JM; Levy, Itzchak I; Elbirt, Daniel D; Chowers, Michal M; Riesenberg, Klaris K; Olstein-Pops, Karen K; Shahar, Eduardo E; Istomin, Valery V; Asher, Ilan I; Gottessman, Bat-Sheva BS; Shemer, Yonat Y; Elinav, Hila H; Hassoun, Gamal G; Rosenberg, Shira S; Averbuch, Diana D; Machleb-Guri, Keren K; Kra-Oz, Zipi Z; Radian-Sade, Sara S; Rudich, Hagit H; Ram, Daniela D; Maayan, Shlomo S; Agmon-Levin, Nancy N; Sthoeger, Zev Z
Publication Date: 2014

Variant appearance in text: HR: N83D
PubMed Link: 24475093
Variant Present in the following documents:
  • Main text
  • pone.0086239.pdf
View BVdb publication page



The interaction of DiaA and DnaA regulates the replication cycle in E. coli by directly promoting ATP DnaA-specific initiation complexes.

Genes & Development
Keyamura, Kenji K; Fujikawa, Norie N; Ishida, Takuma T; Ozaki, Shogo S; Su'etsugu, Masayuki M; Fujimitsu, Kazuyuki K; Kagawa, Wataru W; Yokoyama, Shigeyuki S; Kurumizaka, Hitoshi H; Katayama, Tsutomu T
Publication Date: 2007-08-15

Variant appearance in text: HR: N83D
PubMed Link: 17699754
Variant Present in the following documents:
  • Main text
View BVdb publication page